| 000 | 01569 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515174443.0 | ||
| 264 | 0 | _c20090925 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1528-1159 | ||
| 024 | 7 |
_a10.1097/BRS.0b013e31819e2c78 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiliang, Po-Chou | |
| 245 | 0 | 0 |
_aThe therapeutic efficacy of sacroiliac joint blocks with triamcinolone acetonide in the treatment of sacroiliac joint dysfunction without spondyloarthropathy. _h[electronic resource] |
| 260 |
_bSpine _cApr 2009 |
||
| 300 |
_a896-900 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthralgia _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intra-Articular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSacroiliac Joint _xdrug effects |
| 650 | 0 | 4 |
_aSpondylarthropathies _xpathology |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriamcinolone Acetonide _xadministration & dosage |
| 700 | 1 | _aLu, Kang | |
| 700 | 1 | _aWeng, Hui-Ching | |
| 700 | 1 | _aLiang, Cheng-Loong | |
| 700 | 1 | _aTsai, Yu-Duan | |
| 700 | 1 | _aChen, Han-Jung | |
| 773 | 0 |
_tSpine _gvol. 34 _gno. 9 _gp. 896-900 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BRS.0b013e31819e2c78 _zAvailable from publisher's website |
| 999 |
_c18950662 _d18950662 |
||